AVROBIO, Inc. (AVRO) Financials
Stock symbol AVRO is outdated, potentially delisted? Maybe it is available on other exchange?
AVRO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 101.1 million | 6.4 million |
| Sept. 30, 2023 | 110.5 million | 7.7 million |
| June 30, 2023 | 133.8 million | 11.8 million |
| March 31, 2023 | 83.0 million | 30.0 million |
AVRO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -8.0 million | 607000 |
| Sept. 30, 2023 | -20.2 million | 2.2 million |
| June 30, 2023 | -14.7 million | 1.5 million |
| March 31, 2023 | -20.3 million | 2.5 million |
AVRO Net Income
No data available :(
AVRO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 98.3 million | - | 878000 |
| Sept. 30, 2023 | 105.8 million | - | 1.8 million |
| June 30, 2023 | 124.7 million | - | 2.4 million |
| March 31, 2023 | 72.3 million | 15.4 million | 3.0 million |
AVRO Shares Outstanding
AVRO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | - | 4.4 million | 5.2 million | - |
| Sept. 30, 2023 | - | 14.8 million | 6.3 million | - |
| June 30, 2023 | - | 11.1 million | 4.6 million | - |
| March 31, 2023 | 8000 | 17.3 million | 7.9 million | - |
AVRO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | - |
| Sept. 30, 2023 | - | - |
| June 30, 2023 | - | 879000 |
| March 31, 2023 | - | 920000 |
AVRO
Price: $1.40
52 week price:
Earnings Per Share: 0.69 USD
P/E Ratio: 2.20
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 362600
Market Capitalization: 68.2 million